Dechert Advises Blackstone Tactical Opportunities in Genstar Capital’s Recapitalization of ConnectiveRx
March 11, 2020
Dechert advised Blackstone Tactical Opportunities as an investor in connection with Genstar Capital’s recapitalization of its portfolio company ConnectiveRx. Genstar will continue as majority investor and will be joined by funds managed by Harvest Partners SCF, LP and funds managed by Blackstone Tactical Opportunities as minority investors.
Blackstone Tactical Opportunities (Tac Opps) is Blackstone’s opportunistic investment platform. Genstar Capital is a leading private equity firm. ConnectiveRx is a leading, technology-enabled biopharmaceutical services company that provides patient and provider support, access and adherence solutions for specialty and branded medications.
The Dechert team advising Blackstone Tactical Opportunities includes corporate partners Ken Young and Jonathan Stott and associate Quinn Wetherall; finance partner Samantha Koplik; and tax partner Steven Clemens and associate George Davis.
About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
